Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Ignoffo

Cancer practice

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Practice|October 10, 1998
Capecitabine: A new oral fluoropyrimidineR J Ignoffo
Cancer Practice|March 1, 1994
Chemoprotectants in oncologyR J Ignoffo
Cancer Practice|May 1, 1994
GranisetronR J Ignoffo
Cancer Practice|March 20, 2002
Temozolomide. A new option for high-grade astrocytomasJ Schwenka, R J Ignoffo
Cancer Practice|October 28, 1997
Dolasetron. A new 5-hydroxytryptamine3 receptor antagonistY F Hui, R J Ignoffo
Cancer Practice|March 1, 1997
Docetaxel in anthracycline-resistant metastatic breast cancerY F Hui, R J Ignoffo
Cancer Practice|March 7, 2002
Arsenic trioxide for the treatment of acute promyelocytic leukemiaM S Lam, R J Ignoffo
Cancer Practice|February 14, 1998
Angiogenesis inhibitors. A promising role in cancer therapyY F Hui, R J Ignoffo
Cancer Practice|September 1, 1995
Vinorelbine tartrateB M Chan, R J Ignoffo
Cancer Practice|September 1, 1996
Liposomal doxorubicinK F Linsky, R J Ignoffo
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Practice|October 10, 1998
Capecitabine: A new oral fluoropyrimidineR J Ignoffo
Cancer Practice|March 1, 1994
Chemoprotectants in oncologyR J Ignoffo
Cancer Practice|May 1, 1994
GranisetronR J Ignoffo
Cancer Practice|March 20, 2002
Temozolomide. A new option for high-grade astrocytomasJ Schwenka, R J Ignoffo
Cancer Practice|October 28, 1997
Dolasetron. A new 5-hydroxytryptamine3 receptor antagonistY F Hui, R J Ignoffo
Cancer Practice|March 1, 1997
Docetaxel in anthracycline-resistant metastatic breast cancerY F Hui, R J Ignoffo
Cancer Practice|March 7, 2002
Arsenic trioxide for the treatment of acute promyelocytic leukemiaM S Lam, R J Ignoffo
Cancer Practice|February 14, 1998
Angiogenesis inhibitors. A promising role in cancer therapyY F Hui, R J Ignoffo
Cancer Practice|September 1, 1995
Vinorelbine tartrateB M Chan, R J Ignoffo
Cancer Practice|September 1, 1996
Liposomal doxorubicinK F Linsky, R J Ignoffo
Pageof 1